Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. on January 24, 2024, covering an event that occurred on January 23, 2024. The Company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a capital structure transaction.
Material Changes
The Company reported the issuance of 546,776 shares of common stock resulting from the conversion of 875 shares of outstanding Series A Convertible Preferred Stock. Each share of Series A Preferred Stock converted into approximately 625 shares of common stock. The transaction was executed under the exemption in Section 3(a)(9) of the Securities Act of 1933, as no commission was paid for soliciting the exchange. The newly issued shares are registered for resale on an effective Form S-1.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items beyond the specific equity conversion event.
Key Facts for Investor Verification
- Verify the total number of common shares outstanding post-conversion.
- Confirm the effective status of the Form S-1 registration statement for the resale of the 546,776 shares.
- Review the terms of the Series A Convertible Preferred Stock to understand remaining conversion obligations.
- Check for any subsequent filings regarding the dilution impact on existing shareholders.